← Back to Patent Explorer
US4594346A Expired / Lapsed US ⏱️ 0.0 years remaining

3,6-disubstituted-1,8-naphthalimides and methods for their production and use

Assignee: Warner Lambert Co LLC
•
Filing: 1985-01-22
•
Granted: 1986-06-10
•
Expires: 2005-01-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Chemical compounds are provided that are novel 3,6-disubstituted-1,8-naphthalimides (I), as well as methods for their production, pharmaceutical compositions comprising the compounds, and methods of treatment using the compounds in dosage form. Compounds of the invention have pharmacological properties and are useful antimicrobial agents. ##STR1##

Inventors

  • 👤 Robert K. Zee-Cheng
  • 👤 Chia C. Cheng

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 07:12
CPC Classifications
C; C07; C07D; C07D221/00; C07D221/02; C07D221/04; C07D221/06; C07D221/14

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 79 words
A method for treating transplantable leukemia in a lower mammal which comprises administering an antileukemically effective amount of a compound having in free base form the structural formula I ##STR8## or a pharmaceutically acceptable salt thereof, where n is 2 or 3, R 1 and R 2 are H, lower alkyl, lower hydroxyalkyl, pyrrolidinyl, morpholino, or piperidinyl, and Y is NO 2 or HN 2 , in combination with a pharmaceutically acceptable carrier, to a mammal in need thereof.
Claim 2
Independent Claim 79 words
A method for treating transplantable leukemia in a lower mammal which comprises administering an antileukemically effective amount of a compound having in free base form the structural formula I ##STR8## or a pharmaceutically acceptable salt thereof, where n is 2 or 3, R 1 and R 2 are H, lower alkyl, lower hydroxyalkyl, pyrrolidinyl, morpholino, or piperidinyl, and Y is NO 2 or HN 2 , in combination with a pharmaceutically acceptable carrier, to a mammal in need thereof.

References Cited (Backward Citations)

US3940398A Cited
US4146720A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-06-09 1989-12-09 1990-06-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-06-09 1993-12-09 1994-06-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-06-09 1997-12-09 1998-06-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag